CEVR analyzes the benefits, risks, and costs of strategies to improve health and health care.

About Us

News & Events

The Best Books I Read in 2022

Date: December 7, 2022By Peter Neumann, ScD, Director The Best Books I Read in 2022 The two questions I am asked most frequently since I began pos...

Read more December 7, 2022
2023 CEA Registry Remote Summer Fellowship

What is CEVR and the CEA Registry? CEVR is a leading research center on issues pertaining to value, cost-effectiveness, and risk tradeoffs in healthca...

Read more November 2, 2022
Behind the Scenes with Elle Pope: Senior Reader for the CEA Registry

Date: December 2, 2022Behind the Scenes with Elle Pope: Senior Reader for the CEA Registry Ever wonder how the Cost-Effectiveness Analysis (CEA) Re...

Read more December 2, 2022
View All News & Events

Recent Publications

Health Affairs Forefront
Options for CMS drug price negotiations
View publication
January 4, 2023
Patient Preference and Adherence
Patient and caregiver views on measures of the value of health interventions
View publication
December 20, 2022
Value in Health
The impact on cost-effectiveness of accounting for generic drug pricing: Four case studies
View publication
November 3, 2022
Applied Health Economics and Health Policy
Family spillover effects: Are economic evaluations misrepresenting the value of healthcare interventions to society?
View publication
August 23, 2022
Journal of Managed Care & Specialty Pharmacy
When are breakthrough therapies cost-effective?
View publication
July 28, 2022
JAMA Network Open
Racial and ethnic differences in hospice use and hospitalizations at end-of-life among Medicare beneficiaries with dementia
View publication
June 9, 2022
Medical Decision Making
Trends in author-reported cost-effectiveness thresholds in the United States from 1995 to 2018: Implications for discount rates
View publication
May 7, 2022
The American Journal of Managed Care
Patients’ access to 2018 FDA-approved drugs 1 year post approval
View publication
April 12, 2022
PharmacoEconomics
Addressing challenges to alternative payment models for new Alzheimer’s disease therapies for US commercial payers
View publication
May 13, 2022
Genetics in Medicine
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions
View publication
April 8, 2022
Value in Health
A systematic review of economic evaluations of COVID-19 interventions: Considerations of non-health impacts and distributional issues
View publication
April 6, 2022
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases